The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy

被引:345
|
作者
Dorn, Lisa E. [1 ]
Lasman, Lior [3 ]
Chen, Jing [4 ]
Xu, Xianyao [2 ]
Hund, Thomas J. [2 ]
Medvedovic, Mario [4 ]
Hanna, Jacob H. [3 ]
van Berlo, Jop H. [5 ,6 ]
Accornero, Federica [1 ]
机构
[1] Ohio State Univ, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Biomed Engn, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[3] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel
[4] Univ Cincinnati, Dept Environm Hlth, Div Biostat & Bioinformat, Cincinnati, OH 45221 USA
[5] Univ Minnesota, Div Cardiovasc, Lillehei Heart Inst, Minneapolis, MN 55455 USA
[6] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA
基金
英国医学研究理事会; 欧洲研究理事会; 以色列科学基金会; 美国国家卫生研究院;
关键词
gene expression profiling; hypertrophy; mice; transgenic; RNA processing; post-transcriptional; GENE-EXPRESSION; NUCLEAR-RNA; GROWTH; N6-METHYLADENOSINE;
D O I
10.1161/CIRCULATIONAHA.118.036146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:N-6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation in the heart is not known. Methods: To determine the role of m6A methylation in the heart, we isolated primary cardiomyocytes and performed m6A immunoprecipitation followed by RNA sequencing. We then generated genetic tools to modulate m6A levels in cardiomyocytes by manipulating the levels of the m6A RNA methylase methyltransferase-like 3 (METTL3) both in culture and in vivo. We generated cardiac-restricted gain- and loss-of-function mouse models to allow assessment of the METTL3-m6A pathway in cardiac homeostasis and function. Results: We measured the level of m6A methylation on cardiomyocyte mRNA, and found a significant increase in response to hypertrophic stimulation, suggesting a potential role for m6A methylation in the development of cardiomyocyte hypertrophy. Analysis of m6A methylation showed significant enrichment in genes that regulate kinases and intracellular signaling pathways. Inhibition of METTL3 completely abrogated the ability of cardiomyocytes to undergo hypertrophy when stimulated to grow, whereas increased expression of the m6A RNA methylase METTL3 was sufficient to promote cardiomyocyte hypertrophy both in vitro and in vivo. Finally, cardiac-specific METTL3 knockout mice exhibit morphological and functional signs of heart failure with aging and stress, showing the necessity of RNA methylation for the maintenance of cardiac homeostasis. Conclusions: Our study identified METTL3-mediated methylation of mRNA on N-6-adenosines as a dynamic modification that is enhanced in response to hypertrophic stimuli and is necessary for a normal hypertrophic response in cardiomyocytes. Enhanced m6A RNA methylation results in compensated cardiac hypertrophy, whereas diminished m6A drives eccentric cardiomyocyte remodeling and dysfunction, highlighting the critical importance of this novel stress-response mechanism in the heart for maintaining normal cardiac function.
引用
收藏
页码:533 / 545
页数:13
相关论文
共 50 条
  • [21] Widespread occurrence of N6-methyladenosine in bacterial mRNA
    Deng, Xin
    Chen, Kai
    Luo, Guan-Zheng
    Weng, Xiaocheng
    Ji, Quanjiang
    Zhou, Tianhong
    He, Chuan
    NUCLEIC ACIDS RESEARCH, 2015, 43 (13) : 6557 - 6567
  • [22] N6-methyladenosine Methyltransferase METTL3 Enhances PTGER2 Expression to Increase Ovarian Cancer Stemness and Chemoresistance
    Lin, Yi-Bin
    Xu, Ben-Hua
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (09):
  • [23] N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis
    Shen, Hao
    Xie, Keliang
    Tian, Yikui
    Wang, Xiaoye
    APOPTOSIS, 2023, 28 (3-4) : 514 - 524
  • [24] METTL3-mediated N6-methyladenosine modification of MMP9 mRNA promotes colorectal cancer proliferation and migration
    Chen, Jie
    Wu, Henglan
    Zuo, Ting
    Wu, Jianming
    Chen, Zhiheng
    ONCOLOGY REPORTS, 2025, 53 (01)
  • [25] METTL3 inhibition reduces N6-methyladenosine levels and prevents allogeneic CD4+ T-cell responses
    Li, Shuang
    Zou, Dawei
    Chen, Wenhao
    Britz, Gavin W.
    Liu, Zhaoqian
    Weng, Yi-Lan
    IMMUNOLOGY AND CELL BIOLOGY, 2022, 100 (09) : 718 - 730
  • [26] METTL3-Mediated N6-methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis
    Tsai, Yu-Cheng
    Hsieh, Tsung-Han
    Liao, Yuan-Ru
    Tsai, Ming-Tsun
    Lin, Tzu-Ping
    Lee, Der-Yen
    Park, Jihwan
    Kim, Donggun
    Susztak, Katalin
    Yang, Shang-Feng
    Lin, Chih-Ching
    Li, Szu-Yuan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10): : 1312 - 1329
  • [27] Regulation of Virus Replication and T Cell Homeostasis by N6-Methyladenosine
    Yang, Jing
    Wang, Hong
    Zhang, Wenyan
    VIROLOGICA SINICA, 2019, 34 (01) : 22 - 29
  • [28] The role of N6-methyladenosine mRNA in the tumor microenvironment
    Li, Min
    Zha, Xuan
    Wang, Shengjun
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1875 (02):
  • [29] N6-methyladenosine methyltransferase METTL3 modulates the cell cycle of granulosa cells via CCND1 and AURKB in Haimen goats
    Liu, Zifei
    Zhou, Lei
    Li, Dongxu
    Lu, Honghui
    Liu, Liang
    Mao, Weijia
    Yu, Xiaoqing
    Fan, Yixuan
    Huang, Qunhao
    Wang, Feng
    Wan, Yongjie
    FASEB JOURNAL, 2023, 37 (11)
  • [30] The N6-methyladenosine writer METTL3 promotes breast cancer progression through YTHDF2-dependent posttranscriptional silencing of GSDMD
    Shuai, You
    Ma, Zhonghua
    Ju, Jie
    Li, Chunxiao
    Bai, Xiaorong
    Yue, Jian
    Wang, Xue
    Yuan, Peng
    Qian, Haili
    APOPTOSIS, 2025, 30 (1-2) : 226 - 238